Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MedMen Enterprises's share price for the quarter that ended in Mar. 2023 was $0.0164. MedMen Enterprises's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 1,383.2 Mil. Therefore, MedMen Enterprises's market cap for the quarter that ended in Mar. 2023 was $22.7 Mil.
MedMen Enterprises's quarterly market cap
declined
from Sep. 2022 ($50.8 Mil) to Dec. 2022 ($18.9 Mil) but then
increased
from Dec. 2022 ($18.9 Mil) to Mar. 2023 ($22.7 Mil).
MedMen Enterprises's annual market cap
increased
from Jun. 2020 ($92.1 Mil) to Jun. 2021 ($161.3 Mil) but then
declined
from Jun. 2021 ($161.3 Mil) to Jun. 2022 ($75.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MedMen Enterprises's Enterprise Value for Today is $0.0 Mil.
MedMen Enterprises (OTCPK:MMNFQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MedMen Enterprises Market Cap Related Terms
MedMen Enterprises Market Cap Historical Data
* Premium members only.
The historical data trend for MedMen Enterprises's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedMen Enterprises Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Market Cap distribution charts can be found below:
* The bar in red indicates where MedMen Enterprises's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MedMen Enterprises's Market Cap for the fiscal year that ended in Jun. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedMen Enterprises (MMNFQ) has a Market Cap of $0.0 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' Market Cap too high?
MedMen Enterprises' current Market Cap is $0.0 Mil.
How does MedMen Enterprises' Market Cap compare to ZTS and VTRS?
MedMen Enterprises' Market Cap of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 206.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.50, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MedMen Enterprises and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedMen Enterprises's current Market Cap is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Market Cap of $0.0 Mil. The current Market Cap is $0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Market Cap is $0.0 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMNFQ has been successfully added to your 